Cargando…
Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
Colorectal cancer (CRC) is the third most common malignant tumor in the world and the second leading cause of cancer-related deaths, with the liver as the most common site of distant metastasis. The prognosis of CRC with liver metastasis is poor, and most patients cannot undergo surgery. In addition...
Autores principales: | Yu, Xianzhe, Zhu, Lingling, Liu, Jiewei, Xie, Ming, Chen, Jiang, Li, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671511/ https://www.ncbi.nlm.nih.gov/pubmed/33223838 http://dx.doi.org/10.2147/OTT.S271955 |
Ejemplares similares
-
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges
por: Zhu, Lingling, et al.
Publicado: (2021) -
A Comprehensive Understanding of Choroidal Metastasis from Lung Cancer
por: Qu, Zihan, et al.
Publicado: (2021) -
Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer
por: Zheng, Wubin, et al.
Publicado: (2021) -
Emerging mechanisms progress of colorectal cancer liver metastasis
por: Zhao, Wenhu, et al.
Publicado: (2022) -
The role of the immunoescape in colorectal cancer liver metastasis
por: Takasu, Chie, et al.
Publicado: (2021)